MYOTONIC DISORDERS
Clinical trials for MYOTONIC DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MYOTONIC DISORDERS trials appear
Sign up with your email to follow new studies for MYOTONIC DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to control debilitating muscle disease
Disease control OngoingThis global Phase 3 trial is testing whether an intravenous drug called AOC 1001 can help control symptoms of myotonic dystrophy type 1, a genetic muscle-wasting disease. About 159 adults with a confirmed diagnosis will receive either the drug or a placebo via infusion every 8 we…
Matched conditions: MYOTONIC DISORDERS
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Four-Year trial tests potential new treatment for debilitating muscle disease
Disease control ENROLLING_BY_INVITATIONThis study is testing the long-term safety and effectiveness of an investigational drug called del-desiran for adults with myotonic dystrophy type 1 (DM1), a genetic muscle-wasting disease. Participants who completed a previous related study will receive an intravenous infusion o…
Matched conditions: MYOTONIC DISORDERS
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC